Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer...

por El Hajj, H., Vanseymortier, M., Hudry, D., Bogart, E., Abdeddaim, C., Leblanc, E., Le Deley, M.C., Narducci, F.
Publicado 2021

A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion

por Bendifallah, S, Canlorbe, G, Raimond, E, Hudry, D, Coutant, C, Graesslin, O, Touboul, C, Huguet, F, Cortez, A, Daraï, E, Ballester, M
Publicado 2014

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?

por Bendifallah, S, Canlorbe, G, Collinet, P, Arsène, E, Huguet, F, Coutant, C, Hudry, D, Graesslin, O, Raimond, E, Touboul, C, Daraï, E, Ballester, M
Publicado 2015

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival

por Houvenaeghel, G, Sabatier, R, Reyal, F, Classe, J M, Giard, S, Charitansky, H, Rouzier, R, Faure, C, Garbay, J R, Daraï, E, Hudry, D, Gimbergues, P, Villet, R, Lambaudie, E
Publicado 2016